DEXWireNews

DEXWireNews

********HOT STOCK FOR THE DAYS TO COME ON THE BACK OF NEW DEBT REFINANCING AGREEMENT ANNOUNCED MONDAY. RALLY STALLED WITH THE MARKET BUT SHOULD SEE GREATER GAINS IN THE DAYS TO COME. BREAK ABOVE THE 50MA AND MACD CROSS NICE SIGNALS FOR A LONG. COMPANY PROFILE Jaguar Health, Inc. is a commercial stage pharmaceuticals company, which engages in the development of...

DEXWireNews

NASDAQ:ATXI TRADED ON HIGH VOLUME AND A INITIAL 30% PRICE SPIKE ON MONDAY BUT SOLD OFF AS THE MARKET CONDITIONS DETERIORATED THROUGHOUT THE DAY. KEEP ON STRONG WATCH AS A MUCH GREATER MOVE IS EXPECTED ON SUCH STRONG RESULTS. COMPANY COMMENTS “The strong safety and efficacy results from this second Phase 3 trial are consistent with those from the first Phase 3...

DEXWireNews

The company today announced that they had received approval to move onto clinical trials on humans with their CD19 t-haNK therapy. TODAY'S STATEMENT “Based on extensive and encouraging preclinical results, we have enhanced our ability to modularly combine this proprietary off-the-shelf t-haNK-based therapy with a wide range of monoclonal antibodies using this...

DEXWireNews

FROM A TECHNICAL PERSPECTIVE THE CHART OF NYSE:CHK IS NOT PRETTY BUT THE PRICE IS REACHING A CRITICAL SUPPORT LEVEL, ON WHICH A REVERSAL TRADE COULD BE VERY PROFITABLE ONE. HOPEFULLY COMMODITIES CAN FIND A BOTTOM TO HELP SUPPORT THIS HORRIFIC SECTOR. SHORT INTEREST 17.47% AVERAGE ANALYSTS PRICE TARGET $3.07 AVERAGE ANALYSTS RECOMMENDATION UNDERWEIGHT P/E...

DEXWireNews

****THERE IS NO LIGHT AT THE END OF THE TUNNEL FOR NYSE:GME EXPECTATIONS FOR TOMORROWS EARNINGS ARE ZERO. THE ONLY HOPE FOR GME IN THE FUTURE IS A TAKEOVER, BUT IT IS HARD TO SEE WHY ANYONE WOULD WANT IT AT$7.50 WHEN THEY COULD GET IT AT $2.50. SHORT INTEREST 39% AVERAGE ANALYSTS PRICE TARGET $9.90 AVERAGE ANALYSTS RECOMMENDATION HOLD COMPANY...

DEXWireNews

*****ON THE WATCHLIST FOR NEXT WEEK AS STOCK HAS BEEN ACTING QUITE BULLISH IN RECENT DAYS***** CAMBRIDGE, Mass., May 29, 2019 /PRNewswire/ -- Infinity Pharmaceuticals, Inc. (INFI) announced today that members of the management team will be participating in the 2019 BIO International Convention at Pennsylvania Convention Center, Philadelphia, PA. Adelene Perkins,...

DEXWireNews

*******June is setting up to a very big month for NASDAQ:NVUS and some very profitable trades may on the offering,. Keep track of the notable dates listed below for results and presentations. Accumulation has already began in anticipation of positive news. ********** AVERAGE ANALYSTS PRICE TARGET $8.75 AVERAGE ANALYSTS RECOMMENDATION BUY UPCOMING MARKET...

DEXWireNews

*******KEEP ON THE WATCHLIST FOR NEXT WEEK, MUCH GREATER MOVES EXPECTED ON MORE NEWS, PURELY SPECULATIVE ***** COMPANY PROFILE Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and...

DEXWireNews

*****HOT STOCK FRIDAY, KEEP ON THE RADAR FOR MAJOR CONTINUATION IN THE DAYS AND WEEKS TO COME.******** AVERAGE TARGET PRICE $25.67 AVERAGE RECOMMENDATION BUY COMPANY DETAILS Genocea is a biopharmaceutical company developing personalized cancer immunotherapies. Our unique ATLAS™ technology platform allows us to identify immunotherapy targets based on each...

DEXWireNews

SPECULATION AND RUMORS HAVE PUT THIS STOCK ON THE WATCHLIST FOR THE WEEKS TO COME, HAD A GOOD DAY ON FRIDAY WITH A 7%SPIKE ON GOOD VOLUME, WHICH MAY HAVE BEEN HAMPERED BY THE MARKET SENTIMENT. STOCK HAS SUFFERED RECENTLY FROM A SPLIT AND OFFERING SO WE AWAIT A POSITIVE CATALYST. COMPANY PROFILE Auris Medical Holding Ltd. engages in the development of novel...

DEXWireNews

******THE STOCK OF NASDAQ:WPRT HAS HAD SOME FANTASTIC PRICE ACTION FOLLOWING A FANTASTIC EARNINGS REPORT WHICH HAS CAPTURED THE ATTENTION OF INVESTORS. LOOK OUT FOR CONTINUATION OF THE TREND TOWARDS $3.60******** RECENT EARNINGS HIGHLIGHTS "Our Q1 2019 results are another validation of our strategy and reflect improved performance across all of our...

DEXWireNews

***$$$$$$$$$$$$$$$$$$$$$$$ASSOCIATION WITH GOOGLE FOR SUCH A SMALL CAP JUST MEANS $$$$$$$$$$$$$$$$$$$$$* Earnings report Highlights Revenues for the three months ended March 31, 2019 decreased by $0.38 million, or 3%, as compared to the three months ended March 31, 2018, mainly because we did not pursue certain low margin, professional services business during...

DEXWireNews

The stock of NASDAQ:HYGS was flagged yesterday for its volume and price spike, resulting in a new 3 year high. We are now on the lookout for continuation and a full scale breakout move. COMPANY PROFILE Hydrogenics Corp. designs, develops and manufactures hydrogen generation and fuel cell products based on water electrolysis technology and proton exchange...

DEXWireNews

*******HOT STOCK TO WATCH , 800,000 SHARES TRADED AFTER HOURS SPIKING THE PRICE 40%, MONSTER MOVES EXPECTED IN THE COMING DAYS.********* Company profile Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in...

DEXWireNews

*****Keep NASDAQ:ICON on your watch-list for some strong moves in the weeks to come, speculation and rumor have brought this to our attention, in confluence with strong price actions and volume today. SHORT INTEREST $22.40 COMPANY PROFILE Iconix Brand Group, Inc. engages in the ownership, licensing and markets a portfolio of consumer brands is a brand...

DEXWireNews

OMG this has been a horrible stock for the last year, its dropped so much even bottom feeders won't touch it. There is still a possible 30% for the shorts to gather before this finds a bottom at 2013 levels. If the trade climate changes with China, get into this as quick as you can, it will rocket higher. Remember just because something is cheap doesn't mean its...

DEXWireNews

*******YOU NEED TO MOVE FAST IN THIS STOCK, ITS ATTRACTING A LOT OF ATTENTION, ALREADY ON A ROLL AND VERY BULLISH SETUP******** Zynga Inc is a US-based company that develops, markets, and operates social games as live services played on mobile platforms, such as iOS and Android, and social networking sites, such as Facebook. Zynga generates revenue through mobile...

DEXWireNews

******UP PRE MARKET 15% BUT THIS COULD RUN A LOT HIGHER ON THE COMPANIES ANNOUNCEMENT OF RESTRUCTURING AND COST CUTTING, EXTREME RELIEF FOR INVESTORS WHOM WANTED A PRO ACTIVE APPROACH MUCH SOONER. ***** AVERAGE PRICE TARGET $20.50 AVERAGE RECOMMENDATION BUY COMPANY PROFILE electroCore, Inc. is a commercial-stage bio-electronic medicine company, with a platform...